A comprehensive analysis of MYO6 as a promising biomarker for diagnosis, prognosis, and immunity in clear cell renal cell carcinoma.

Translational cancer research(2023)

引用 0|浏览4
暂无评分
摘要
The findings suggest that reduced MYO6 expression levels are associated with disease progression, poor prognosis, and immune cell infiltration, and can be considered as a promising prognostic biomarker for ccRCC.
更多
查看译文
关键词
Myosin 6 (MYO6), clear cell renal cell carcinoma (ccRCC), diagnostic, prognosis, immune infiltration
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要